Jim Cramer on Cardinal Health: "I Can See That Stock Going to $300"

Cardinal Health, Inc. (NYSE:CAH) is one of the stocks Jim Cramer discussed, along with market shortages. Mentioning that they like the company, a caller asked for Cramer’s take on it, and he replied:

Oh, Jason Hollar. You know it’s funny… I’m out there. You got all these great drug companies, and who am I most blown away with? Hollar and Cardinal Health, and that urology purchase, the new purchase it just made. You’re dead right. CAH, I can see that stock going to $300.

Cardinal Health, Inc. (NYSE:CAH) supplies branded, generic, and specialty medicines and provides pharmacy and specialty drug services. The company also makes and distributes medical and surgical products and procedure kits. During the January 8 episode, Cramer called the company the “monster” among the drug distributors, as he commented:

The drug distributors continue to relentlessly climb higher. There’s nothing, you know, people hate the pharma middleman. Even the president doesn’t talk, like… them. But I got to tell you, their stocks, they are juggernauts. Cardinal Health, Cencora, and McKesson, they were all up more than 40% last year. Cardinal is really the monster of that group.

While we acknowledge the potential of CAH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.